2m 2m 2m 2m 2m 2m 2m
Amphastar Pharma (AMPH)
NASDAQ
$24.08+$0.30 (+1.26%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.0BMarket Cap
- -15.25%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Amphastar Pharma (AMPH)
$24.08+$0.30 (+1.26%)
AMPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.78 | ||
Change | +$0.24 (+1.02%) | ||
Open | $23.65 | ||
High | $23.80 | ||
Low | $23.24 | ||
Previous Close | $23.54 | ||
Volume | 418,054 | ||
30-Day Average Volume | 398,790 | ||
1-Week Change | 2.59% | ||
1-Month Change | 16.45% | ||
1-Year Change | -15.25% | ||
3-Year Change | -53.71% | ||
5-Year Change | 33.37% | ||
Fundamentals | |||
Shares Outstanding | 42.5M | ||
Total Assets | $1.7B | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | $30.3M | ||
Free Cash Flow | $42.7M | ||
EBIT | $40.8M | ||
EBITDA | $47.1M | ||
Net Working Capital | $367.7M | ||
EPS | $0.67 | ||
Enterprise Value/EBITDA | 30 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 35 | ||
PEG | 0 | ||
Price/Free Cash Flow | 24 | ||
Price/Operating Cash Flow | 20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue